CAPR vs HAL · $1.62B cap vs P/E 9.3, $19.05B cap
Capricor Therapeutics Inc (CAPR) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CAPR currently screens at market cap $1.62B.
HAL does not have a complete income-statement cache yet.
CAPR currently screens at market cap $1.62B. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the CAPR and HAL stock pages for the full models.
Not investment advice.